CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- 4 Open-market sale President and CEO sold 2,692 shares at $1.66 ($4,470)
- 4 Open-market sale President and CEO sold 4,768 shares at $1.85 ($8,810)
- 4 Open-market buy Director bought 130,000 shares at $1.15 ($149,799)
- 4 Option exercise President and CEO acquired 10,938 shares (option exercise)
- 4 Open-market buy Director bought 50,000 shares at $0.77 ($38,720)
- 4 Open-market buy Director bought 6,681,600 shares
- 4 Open-market sale President and CEO sold 5,443 shares at $1.81 ($9,863)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 3,226 shares at $3.09 ($9,955)
- 4 Open-market sale Chief Scientific Officer sold 3,416 shares at $3.09 ($10,541)
- 4 Open-market sale Chief Operations Officer sold 3,416 shares at $3.09 ($10,541)
- 4 Open-market sale President and CEO sold 13,597 shares at $3.09 ($41,959)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 90,200 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 72,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Scientific Officer acquired 72,000 shares (grant or award)
- 4 Grant or award Chief Operations Officer acquired 72,000 shares (grant or award)
Page 8 of 21 · 410 filings